Remote Glucose Monitoring Platform for Multiple Simultaneous Patients at Coronavirus Disease 2019 Intensive Care Units: Case Report including Adults and Children

GARELLI, FABRICIO; ROSALES, NICOLÁS; FUSHIMI, EMILIA; ARAMBARRI, DELFINA; MENDOZA, LEANDRO; DE BATTISTA, HERNÁN; SÁNCHEZ-PEÑA, RICARDO; GARCÍA ARABEHETY, JULIA; DISTEFANO, SABRINA; BARCALA, CONSUELO; GIUNTA, JAVIER; LAS HERAS, MARCOS; MARTINEZ MATEU, CAROLINA; PRIETO, MARIANA; SAN ROMÁN, EDUARDO; KROCHIK, GABRIELA; GROSEMBACHER, LUIS

DIABETES TECHNOLOGY & THERAPEUTICS

MARY ANN LIEBERT INC

Año: 2021 vol. 23 p. 471 - 473

1520-9156

From the beginning of the pandemic, a lot of articles have been written about the relevance of technology and remote glucose monitoring to deal with diabetes within the present context.1 However, not so many reports have been published on its actual implementation in critically ill patients. In Ushigome et al.,2 a single case of glucose monitoring in a critical patient was reported, using a Continuous Glucose Monitor (CGM) Dexcom G4, which should be read at a maximum distance of 6 m from the patient. In Shehav-Zaltzman et al.,3 four patients were remotely monitored using Medtronic CGMs and web-app CareLink accessed through minimized browser windows. Finally, remote monitoring with Dexcom G6 was evaluated using Dexcom Follow app in Reutrakul et al.4 for noncritical patients with coronavirus disease 2019 (COVID-19). Other relevant telemetry studies worth to mention that controlled multiple patients without COVID-19 are Beardsall et al.5 and Singh et al.6This letter illustrates the potential of a new platform for simultaneous remote monitoring of multiple intensive care unit (ICU) and/or quarantined patients. To our best knowledge, this is the first multicenter, multisensor, multipatient, and potentially multitherapy platform for remote glucose monitoring employed in critically ill COVID patients. We report the real-time remote monitoring of five COVID-19 positive ICU patients, two children and three adults, together with an ambulatory patient to test the platform versatility and long-term performance. As far as we know, also, this is the first multiple ICU monitoring experience, including critical pediatric COVID positive cases.